Special Issue "Wnt Pathway Targets in Cancer"
Deadline for manuscript submissions: 20 December 2023 | Viewed by 7356
Interests: Wnt signaling; cancers of liver and pancreas; metabolism; fibrosis
Special Issues, Collections and Topics in MDPI journals
Interests: Wnt signaling; hepatocellular carcinoma (HCC); liver tumor-initiating cells (T-ICs)/cancer stem cells (CSCs); cancer drug resistance; gut microbiota in cancer development
Interests: Wnt signaling; liver cancer; liver development; adult hepatocyte stem cells; liver cell atlas; acute hepatic porphyrias
Dysregulation of Wnt signaling is known to be associated with various cancers. As such, identification of novel Wnt pathway targets in cancer and better characterization of already-known targets present exciting, emerging opportunities for cancer treatment and perhaps even prevention. In this Special Issue, we propose to cover Wnt pathway targets in cancer, with a focus on solid tumors, especially highly lethal cancers of the liver (e.g., HCC), pancreas (e.g., PDAC), and GI tract. Topics may include but are not limited to the role(s) of Wnt pathway targets in cancer stem cells, nonparenchymal cells, cancer metabolism, tumor immune response, and tumor microenvironment. Original research articles, review articles, as well as short communications are invited for this Special Issue.
We look forward to receiving your contributions.
Dr. Keane Lai
Dr. Terence K.W. Lee
Dr. Bruce Wang
Dr. David W. Dawson
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- gastrointestinal tract
- hepatocellular carcinoma
- pancreatic ductal adenocarcinoma
- gastric cancer
- colon cancer
- solid tumors